Head and neck cancer

March 21, 2025
March 21, 2025
Categories

Amended Trial: David Sher Gives an Update on the EA3211 Trial for Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck

The changes significantly broaden eligibility and clarify key details in this phase 3 trial exploring whether adding radiation therapy to standard immunotherapy will improve survival in patients with stable disease after initial treatment
Do you like it?
0 Read more
October 17, 2024
Woman talking with doctor
October 17, 2024
Categories

Amended Trial: Robert Ferris Gives an Update on the EA3132 Trial for Patients with Head and Neck Cancer

The changes aim to alleviate scheduling difficulties during the randomization step, and they introduce the new tumor test for this phase 2 trial testing radiotherapy with or without chemotherapy
Do you like it?
0 Read more
August 25, 2023
Doctor examining patient's neck
August 25, 2023
Categories

Now Enrolling: EA3211 for Patients with Squamous Cell Carcinoma of the Head and Neck

This phase 3 study of oligometastatic head and neck cancer is exploring whether it is more effective to add radiation therapy to standard immunotherapy in patients with stable disease after initial chemotherapy plus immunotherapy
Do you like it?
0 Read more
December 20, 2022
Woman talking with doctor
December 20, 2022
Categories

Trial Spotlight: Robert Ferris and Christine Chung on the EA3132 Trial for Patients with Head and Neck Cancer

This phase 2 study is examining whether the addition of cisplatin to PORT will provide a survival benefit to certain patients with stage 3/4 squamous cell carcinoma of the head and neck
Do you like it?
0 Read more
12